Kevin Wall
Family Medicine · Manhattan, KSNPI 1285673087
Payments from drug & device makers
Across 316 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$605
- Pfizer$429
- Amgen$425
- Novo Nordisk$347
- AstraZeneca$322
- Lilly USA, LLC$278
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$200%
- Food & beverage$4,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $605 |
| Pfizer | 37 | $429 |
| Amgen | 36 | $425 |
| Novo Nordisk | 27 | $347 |
| AstraZeneca | 15 | $322 |
| Lilly USA, LLC | 24 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $247 |
| Amarin Pharma, Inc. | 12 | $218 |
| Johnson & Johnson | 10 | $202 |
| Boehringer Ingelheim | 13 | $197 |
| GSK | 13 | $194 |
| Jazz Pharmaceuticals Inc. | 2 | $126 |
| Sanofi-aventis U.S. LLC | 8 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $101 |
| Teva Pharmaceuticals USA, Inc. | 7 | $99 |
| Bayer | 6 | $76 |
| Astellas Pharma US Inc | 5 | $65 |
| Eisai Inc. | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $57 |
| Merck | 4 | $48 |
| Novartis | 2 | $37 |
| Radius Health, Inc. | 3 | $35 |
| Grifols USA, LLC | 2 | $32 |
| Dexcom, Inc. | 1 | $29 |
| Nevro Corp. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 2 | $24 |
| Abbott | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Corium, LLC | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,489 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $15,130 |
| JardianceEmpagliflozin | 12 | $9,690 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,830 |
| Novolog FlexpenInsulin Aspart | 11 | $2,884 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $847 |
| Atorvastatin Calcium | 121 | $619 |
| Omeprazole | 34 | $342 |
| Olmesartan Medoxomil | 14 | $310 |
| Pantoprazole Sodium | 21 | $292 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $259 |
| Tamsulosin Hcl | 34 | $228 |
| Lisinopril | 42 | $184 |
| Amlodipine Besylate | 66 | $167 |
| Metoprolol Succinate | 14 | $160 |
| Escitalopram Oxalate | 12 | $157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $429 | $15,13016 claims |
| Boehringer IngelheimJardiance | $197 | $9,69012 claims |
| GSKIncruse Ellipta | $194 | $3,83011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Manhattan
- Bradley HarrisonManhattan$314K
- Kent KiracofeManhattan$189K
- Kyle PlatzManhattan$51K
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.